2011 Q4 Form 10-Q Financial Statement

#000117891311003007 Filed on November 09, 2011

View on sec.gov

Income Statement

Concept 2011 Q4 2011 Q3 2010 Q3
Revenue $231.00 $154.0K
YoY Change
Cost Of Revenue $7.00 $5.000K
YoY Change
Gross Profit $224.00 $149.0K
YoY Change
Gross Profit Margin 96.97% 96.75%
Selling, General & Admin $1.280M $1.640M $760.0K
YoY Change 2.4% 115.79% -1.3%
% of Gross Profit 571428.57% 1100.67%
Research & Development $2.969K $2.863M $1.501M
YoY Change -99.86% 90.74% 10.37%
% of Gross Profit 1325.45% 1921.48%
Depreciation & Amortization $100.0K $97.00K $70.00K
YoY Change 42.86% 38.57% 40.0%
% of Gross Profit 44642.86% 65.1%
Operating Expenses $2.349M $4.486M $1.754M
YoY Change -16.82% 155.76% 6.95%
Operating Profit -$2.118K -$4.332M -$1.754M
YoY Change -99.93% 146.98%
Interest Expense $130.0K -$160.0K $70.00K
YoY Change -328.57% 250.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.990M -$4.490M -$1.690M
YoY Change -29.43% 165.68% 4.32%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.992K -$4.493M -$1.689M
YoY Change -99.93% 166.02% 4.26%
Net Earnings / Revenue -862.34% -2917.53%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.46 -$1.05 -$0.80
COMMON SHARES
Basic Shares Outstanding 43.78M
Diluted Shares Outstanding

Balance Sheet

Concept 2011 Q4 2011 Q3 2010 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $41.52M $45.80M $1.640M
YoY Change 775.95% 2692.68% -23.36%
Cash & Equivalents $6.672K $13.63M $1.127M
Short-Term Investments $34.84M $32.17M $520.0K
Other Short-Term Assets $220.0K $330.0K $80.00K
YoY Change 266.67% 312.5% -38.46%
Inventory
Prepaid Expenses $217.0K $334.0K
Receivables $2.110M $230.0K $390.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $43.84M $46.36M $2.110M
YoY Change 692.82% 2097.3% -18.85%
LONG-TERM ASSETS
Property, Plant & Equipment $2.883M $2.156M $1.760M
YoY Change 58.41% 22.5% 40.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.190M $870.0K $170.0K
YoY Change 561.11% 411.76% 0.0%
Other Assets $1.245M $460.0K $330.0K
YoY Change 245.83% 39.39% 73.68%
Total Long-Term Assets $5.799M $3.481M $2.260M
YoY Change 146.77% 54.03% 40.37%
TOTAL ASSETS
Total Short-Term Assets $43.84M $46.36M $2.110M
Total Long-Term Assets $5.799M $3.481M $2.260M
Total Assets $49.64M $49.84M $4.370M
YoY Change 529.97% 1040.59% 3.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.174M $1.076M $670.0K
YoY Change 26.24% 60.6% 36.73%
Accrued Expenses $231.0K $376.0K $160.0K
YoY Change 156.67% 135.0% 100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.976M $5.045M $1.230M
YoY Change 236.22% 310.16% 38.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.310M $4.510M $400.0K
YoY Change 926.19% 1027.5% 60.0%
Total Long-Term Liabilities $4.314M $4.505M $400.0K
YoY Change 927.14% 1026.25% 60.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.976M $5.045M $1.230M
Total Long-Term Liabilities $4.314M $4.505M $400.0K
Total Liabilities $9.290M $9.550M $1.630M
YoY Change 388.95% 485.89% 42.98%
SHAREHOLDERS EQUITY
Retained Earnings -$57.44M -$55.45M
YoY Change
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $40.35K $40.29M $2.730M
YoY Change
Total Liabilities & Shareholders Equity $49.64M $49.84M $4.370M
YoY Change 529.97% 1040.59% 3.8%

Cashflow Statement

Concept 2011 Q4 2011 Q3 2010 Q3
OPERATING ACTIVITIES
Net Income -$1.992K -$4.493M -$1.689M
YoY Change -99.93% 166.02% 4.26%
Depreciation, Depletion And Amortization $100.0K $97.00K $70.00K
YoY Change 42.86% 38.57% 40.0%
Cash From Operating Activities -$3.290M $3.461M -$688.0K
YoY Change 115.03% -603.05% -26.81%
INVESTING ACTIVITIES
Capital Expenditures $820.0K $179.0K $426.0K
YoY Change 530.77% -57.98% 752.0%
Acquisitions
YoY Change
Other Investing Activities -$2.940M $690.0K $430.0K
YoY Change -688.0% 60.47%
Cash From Investing Activities -$3.750M -$32.98M $4.000K
YoY Change -1113.51% -824600.0% -108.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $252.0K
YoY Change -100.0% -68.1%
Debt Paid & Issued, Net $24.00K
YoY Change
Cash From Financing Activities 80.00K $323.0K $228.0K
YoY Change -98.33% 41.67% -71.14%
NET CHANGE
Cash From Operating Activities -3.290M $3.461M -$688.0K
Cash From Investing Activities -3.750M -$32.98M $4.000K
Cash From Financing Activities 80.00K $323.0K $228.0K
Net Change In Cash -6.960M -$29.20M -$456.0K
YoY Change -292.27% 6302.63% 128.0%
FREE CASH FLOW
Cash From Operating Activities -$3.290M $3.461M -$688.0K
Capital Expenditures $820.0K $179.0K $426.0K
Free Cash Flow -$4.110M $3.282M -$1.114M
YoY Change 147.59% -394.61% 12.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q3 dei Amendment Flag
AmendmentFlag
false
CY2011Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2011Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2011Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2011Q3 dei Document Period End Date
DocumentPeriodEndDate
2011-09-30
CY2011Q3 dei Document Type
DocumentType
10-Q
CY2011Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001158780
CY2011Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
43779291
CY2011Q3 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2011Q3 dei Entity Registrant Name
EntityRegistrantName
PLURISTEM THERAPEUTICS INC
CY2011Q3 psti Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities
AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities
4000 USD
CY2011Q3 psti Exercise Of Warrants By Investors And Finders
ExerciseOfWarrantsByInvestorsAndFinders
315000 USD
CY2011 psti Exercise Of Warrants By Investors And Finders
ExerciseOfWarrantsByInvestorsAndFinders
3593000 USD
CY2011Q3 psti Financial Income Expense Net
FinancialIncomeExpenseNet
-161000 USD
CY2010Q3 psti Financial Income Expense Net
FinancialIncomeExpenseNet
65000 USD
CY2011 psti Financial Income Expense Net
FinancialIncomeExpenseNet
266000 USD
CY2011 psti Issuance Of Common Stock And Warrants Related To February2011 Agreement
IssuanceOfCommonStockAndWarrantsRelatedToFebruary2011Agreement
38142000 USD
CY2011 psti Issuance Of Common Stock And Warrants Related To October2010 Agreement
IssuanceOfCommonStockAndWarrantsRelatedToOctober2010Agreement
5006000 USD
CY2011 psti Issuance Of Common Stock Related To Investors Relation Agreements
IssuanceOfCommonStockRelatedToInvestorsRelationAgreements
155000 USD
CY2011Q3 psti Linkage Differences And Interest On Long Term Restricted Lease Deposit
LinkageDifferencesAndInterestOnLongTermRestrictedLeaseDeposit
4000 USD
CY2010Q3 psti Linkage Differences And Interest On Long Term Restricted Lease Deposit
LinkageDifferencesAndInterestOnLongTermRestrictedLeaseDeposit
-1000 USD
CY2011 psti Linkage Differences And Interest On Long Term Restricted Lease Deposit
LinkageDifferencesAndInterestOnLongTermRestrictedLeaseDeposit
-4000 USD
CY2011Q3 psti Linkage Differences And Interest On Short Term Restricted Lease Deposit
LinkageDifferencesAndInterestOnShortTermRestrictedLeaseDeposit
15000 USD
CY2011Q3 psti Participation By Office Of Chief Scientist And Other Parties
ParticipationByOfficeOfChiefScientistAndOtherParties
-19000 USD
CY2010Q3 psti Participation By Office Of Chief Scientist And Other Parties
ParticipationByOfficeOfChiefScientistAndOtherParties
-503000 USD
CY2011 psti Participation By Office Of Chief Scientist And Other Parties
ParticipationByOfficeOfChiefScientistAndOtherParties
-1682000 USD
CY2011Q3 psti Purchase Of Property And Equipment In Credit
PurchaseOfPropertyAndEquipmentInCredit
109000 USD
CY2010Q3 psti Purchase Of Property And Equipment In Credit
PurchaseOfPropertyAndEquipmentInCredit
73000 USD
CY2011 psti Purchase Of Property And Equipment In Credit
PurchaseOfPropertyAndEquipmentInCredit
123000 USD
CY2011Q3 psti Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
2849000 USD
CY2010Q3 psti Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
998000 USD
CY2011 psti Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
6629000 USD
CY2011Q3 psti Share Based Compensation To Employees Directors And Non Employees
ShareBasedCompensationToEmployeesDirectorsAndNonEmployees
1041000 USD
CY2010Q3 psti Share Based Compensation To Employees Directors And Non Employees
ShareBasedCompensationToEmployeesDirectorsAndNonEmployees
462000 USD
CY2011 psti Share Based Compensation To Employees Directors And Non Employees
ShareBasedCompensationToEmployeesDirectorsAndNonEmployees
3325000 USD
CY2011Q3 psti Stock Based Compensation To Employees Directors And Non Employees Consultants
StockBasedCompensationToEmployeesDirectorsAndNonEmployeesConsultants
1041000 USD
CY2011 psti Stock Based Compensation To Employees Directors And Non Employees Consultants
StockBasedCompensationToEmployeesDirectorsAndNonEmployeesConsultants
3325000 USD
CY2011Q3 psti Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
42779293
CY2010Q3 psti Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
21012208
CY2011 psti Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
31198825
CY2011Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1076000 USD
CY2011Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1177000 USD
CY2011Q3 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
670000 USD
CY2011Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
633000 USD
CY2011Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
376000 USD
CY2011Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
208000 USD
CY2011Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1000 USD
CY2011Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
95739000 USD
CY2011Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
94375000 USD
CY2011 us-gaap Asset Impairment Charges
AssetImpairmentCharges
11000 USD
CY2011Q3 us-gaap Assets
Assets
49844000 USD
CY2011Q2 us-gaap Assets
Assets
46016000 USD
CY2011Q3 us-gaap Assets Current
AssetsCurrent
46363000 USD
CY2011Q2 us-gaap Assets Current
AssetsCurrent
43297000 USD
CY2011Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
3481000 USD
CY2011Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
2719000 USD
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13633000 USD
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42829000 USD
CY2010Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1583000 USD
CY2010Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1127000 USD
CY2011Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-29196000 USD
CY2010Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-456000 USD
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
41246000 USD
CY2011Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2011Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2011Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2011Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2011Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42985243
CY2011Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42443185
CY2011Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42985243
CY2011Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42443185
CY2011Q3 us-gaap Common Stock Value
CommonStockValue
USD
CY2011Q3 us-gaap Customer Advances Current
CustomerAdvancesCurrent
2000000 USD
CY2011Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
923000 USD
CY2011Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3923000 USD
CY2011Q3 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
459000 USD
CY2011Q2 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
452000 USD
CY2011Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
866000 USD
CY2011Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
179000 USD
CY2011Q3 us-gaap Depreciation
Depreciation
97000 USD
CY2010Q3 us-gaap Depreciation
Depreciation
70000 USD
CY2011 us-gaap Depreciation
Depreciation
312000 USD
CY2011Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2010Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
CY2010Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-8000 USD
CY2011 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-8000 USD
CY2011Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1637000 USD
CY2010Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
756000 USD
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4485000 USD
CY2011Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
8000 USD
CY2010Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
5000 USD
CY2011 us-gaap Income Taxes Paid
IncomeTaxesPaid
11000 USD
CY2011Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-87000 USD
CY2010Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1000 USD
CY2011 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
455000 USD
CY2011Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
205000 USD
CY2010Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
33000 USD
CY2011 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
375000 USD
CY2011Q3 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
74000 USD
CY2010Q3 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
4000 USD
CY2011 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-15000 USD
CY2011Q3 us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
2000000 USD
CY2011Q3 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4846000 USD
CY2011Q3 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
76000 USD
CY2010Q3 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-425000 USD
CY2011 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-656000 USD
CY2011Q3 us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
-1000 USD
CY2010Q3 us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
10000 USD
CY2011 us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
58000 USD
CY2011Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
20000 USD
CY2010Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
39000 USD
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
273000 USD
CY2011Q3 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
-31599000 USD
CY2010Q3 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
36000 USD
CY2011 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
155000 USD
CY2011Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49844000 USD
CY2011Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46016000 USD
CY2011Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5045000 USD
CY2011Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2018000 USD
CY2011Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4505000 USD
CY2011Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
576000 USD
CY2011Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
513000 USD
CY2011Q3 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
1000 USD
CY2011Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
323000 USD
CY2010Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
228000 USD
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
47037000 USD
CY2011Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32980000 USD
CY2010Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4000 USD
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36000 USD
CY2011Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3461000 USD
CY2010Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-688000 USD
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5755000 USD
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
-4493000 USD
CY2010Q3 us-gaap Net Income Loss
NetIncomeLoss
-1689000 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-10848000 USD
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4332000 USD
CY2010Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1754000 USD
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-11114000 USD
CY2011Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
1000 USD
CY2010Q4 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
244000 USD
CY2011Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2970000 USD
CY2011Q3 us-gaap Payments To Acquire Available For Sale Securities Equity
PaymentsToAcquireAvailableForSaleSecuritiesEquity
516000 USD
CY2011Q3 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
690000 USD
CY2011 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
14000 USD
CY2011Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
179000 USD
CY2010Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
426000 USD
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
962000 USD
CY2011Q3 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
582000 USD
CY2011Q2 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
576000 USD
CY2011Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
334000 USD
CY2011Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
314000 USD
CY2010Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
252000 USD
CY2011 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
43400000 USD
CY2011Q3 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
323000 USD
CY2011 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
3661000 USD
CY2010Q3 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
28000 USD
CY2011 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
29000 USD
CY2011Q3 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
4000 USD
CY2010Q3 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
2000 USD
CY2011 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
13000 USD
CY2010Q3 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
400000 USD
CY2011 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
898000 USD
CY2011Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2156000 USD
CY2011Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2088000 USD
CY2011Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
225000 USD
CY2011Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
154000 USD
CY2010Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
24000 USD
CY2011 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
24000 USD
CY2011Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2868000 USD
CY2010Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1501000 USD
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8311000 USD
CY2011Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-55446000 USD
CY2011Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-50953000 USD
CY2011Q3 us-gaap Revenues
Revenues
154000 USD
CY2011Q3 us-gaap Short Term Investments
ShortTermInvestments
31658000 USD
CY2011Q3 us-gaap Stockholders Equity
StockholdersEquity
40294000 USD
CY2011Q2 us-gaap Stockholders Equity
StockholdersEquity
43422000 USD
CY2010Q2 us-gaap Stockholders Equity
StockholdersEquity
3981000 USD
CY2011Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8000 USD
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
68000 USD

Files In Submission

Name View Source Status
0001178913-11-003007-index-headers.html Edgar Link pending
0001178913-11-003007-index.html Edgar Link pending
0001178913-11-003007.txt Edgar Link pending
0001178913-11-003007-xbrl.zip Edgar Link pending
exhibit_31-1.htm Edgar Link pending
exhibit_31-2.htm Edgar Link pending
exhibit_32-1.htm Edgar Link pending
exhibit_32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
psti-20110930.xml Edgar Link completed
psti-20110930.xsd Edgar Link pending
psti-20110930_cal.xml Edgar Link unprocessable
psti-20110930_def.xml Edgar Link unprocessable
psti-20110930_lab.xml Edgar Link unprocessable
psti-20110930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zk1110603.htm Edgar Link pending